About Purilogics
Purilogics is a company based in Clemson (United States) founded in 2013 was acquired by Donaldson Company in June 2022. Purilogics offers products and services including Purexa™ PrA, Purexa™ MCP, Purexa™ NAEX, and Purexa™ OdT. Purilogics operates in a competitive market with competitors including Amyris, Avidity Biosciences, Arbor Biotechnologies, Univercells and Sutro Biopharma, among others.
- Headquarter Clemson, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.19 M (USD), Grant
Aug 01, 2021
-
Investors
Donaldson Company
& 1 more
-
Employee Count
Not available
-
Acquired by
Donaldson Company
(Jun 14, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Purilogics
Purilogics offers a comprehensive portfolio of products and services, including Purexa™ PrA, Purexa™ MCP, Purexa™ NAEX, and Purexa™ OdT.
Membrane for rapid antibody purification in biopharmaceuticals.
Technology for high-volume biologics polishing processes.
Membrane solution for effective nucleic acid purification.
System for fast and consistent therapeutic production.
People of Purilogics
Unlock access to complete
Funding Insights of Purilogics
Investors in Purilogics
Purilogics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Donaldson Company and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Filtration systems are manufactured and supplied globally by Donaldson Company.
|
Locked | Locked | Locked |
Investor details for Purilogics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Purilogics
Investment portfolio details for Purilogics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Purilogics
Detailed financials for Purilogics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Purilogics Comparisons
Peer comparison for Purilogics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Purilogics
Purilogics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Avidity Biosciences, Arbor Biotechnologies, Univercells and Sutro Biopharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Genomic technologies and drug discovery platforms are provided.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
Detailed competitors of Purilogics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Purilogics
Complete news archive for Purilogics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Purilogics
Purilogics was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Purilogics is headquartered in Clemson, United States. It is registered at Clemson, South Carolina, United States.
Purilogics was founded in 2013 and is based in Clemson, United States. Technologies focused on the separation and purification of biomolecules are developed within the biotechnology sector. Operations center on prepacked columns compatible with chromatography systems. The portfolio includes Puri-Q and Puri-MQ for impurity removal during polishing steps, as well as Puri-MC and Puri-A for product recovery from cell culture supernatant.
Purilogics's top competitors include Sutro Biopharma, Avidity Biosciences and Antheia.
Purilogics offers Purexa™ PrA, Purexa™ MCP, Purexa™ NAEX, and Purexa™ OdT.
Purilogics has 2 investors. Key investors include Donaldson Company, and HHS.